1AL7 - Sequence, Chains, Asymmetric and Biological Units

• Title: THREE-DIMENSIONAL STRUCTURES OF GLYCOLATE OXIDASE WITH BOUND SITE INHIBITORS
• Keywords: FLAVOPROTEIN, DRUG DESIGN, INHIBITOR BINDING
• Experiment: X-ray diffraction
• Number of Models: 1

Database	ID code	Status	Coordinate files
			Header	Asymmetric unit	Biological unit
PDB	1AL7	released	available	available	Quaternary Structure Server

Asymmetric unit from PDB

Unit	Type	Name	Chain ID	Residues	Atoms	Hetatoms
1	Protein	GLYCOLATE OXIDASE	A	350	2697	0
2	Ligand	GLYCOLATE OXIDASE	A	2	0	51
3	Water			292	0	292
total				644	2697	343

Proteins

Unit 1

MET 1 GLU 2 ILE 3 THR 4 ASN 5 VAL 6 ASN 7 GLU 8 TYR 9 GLU 10 ALA 11 ILE 12 ALA 13 LYS 14 GLN 15 LYS 16 LEU 17 PRO 18 LYS 19 MET 20 VAL 21 TYR 22 ASP 23 TYR 24 TYR 25 ALA 26 SER 27 GLY 28 ALA 29 GLU 30 ASP 31 GLN 32 TRP 33 THR 34 LEU 35 ALA 36 GLU 37 ASN 38 ARG 39 ASN 40 ALA 41 PHE 42 SER 43 ARG 44 ILE 45 LEU 46 PHE 47 ARG 48 PRO 49 ARG 50 ILE 51 LEU 52 ILE 53 ASP 54 VAL 55 THR 56 ASN 57 ILE 58 ASP 59 MET 60 THR 61 THR 62 THR 63 ILE 64 LEU 65 GLY 66 PHE 67 LYS 68 ILE 69 SER 70 MET 71 PRO 72 ILE 73 MET 74 ILE 75 ALA 76 PRO 77 THR 78 ALA 79 MET 80 GLN 81 LYS 82 MET 83 ALA 84 HIS 85 PRO 86 GLU 87 GLY 88 GLU 89 TYR 90 ALA 91 THR 92 ALA 93 ARG 94 ALA 95 ALA 96 SER 97 ALA 98 ALA 99 GLY 100 THR 101 ILE 102 MET 103 THR 104 LEU 105 SER 106 SER 107 TRP 108 ALA 109 THR 110 SER 111 SER 112 VAL 113 GLU 114 GLU 115 VAL 116 ALA 117 SER 118 THR 119 GLY 120 PRO 121 GLY 122 ILE 123 ARG 124 PHE 125 PHE 126 GLN 127 LEU 128 TYR 129 VAL 130 TYR 131 LYS 132 ASP 133 ARG 134 ASN 135 VAL 136 VAL 137 ALA 138 GLN 139 LEU 140 VAL 141 ARG 142 ARG 143 ALA 144 GLU 145 ARG 146 ALA 147 GLY 148 PHE 149 LYS 150 ALA 151 ILE 152 ALA 153 LEU 154 THR 155 VAL 156 ASP 157 THR 158 PRO 159 ARG 160 LEU 161 GLY 162 ARG 163 ARG 164 GLU 165 ALA 166 ASP 167 ILE 168 LYS 169 ASN 170 ARG 171 PHE 172 VAL 173 LEU 174 PRO 175 PRO 176 PHE 177 LEU 178 THR 179 LEU 180 LYS 181 ASN 182 PHE 183 GLU 184 GLY 185 ILE 186 ASP 187 LEU 188 GLY 198 LEU 199 SER 200 SER 201 TYR 202 VAL 203 ALA 204 GLY 205 GLN 206 ILE 207 ASP 208 ARG 209 SER 210 LEU 211 SER 212 TRP 213 LYS 214 ASP 215 VAL 216 ALA 217 TRP 218 LEU 219 GLN 220 THR 221 ILE 222 THR 223 SER 224 LEU 225 PRO 226 ILE 227 LEU 228 VAL 229 LYS 230 GLY 231 VAL 232 ILE 233 THR 234 ALA 235 GLU 236 ASP 237 ALA 238 ARG 239 LEU 240 ALA 241 VAL 242 GLN 243 HIS 244 GLY 245 ALA 246 ALA 247 GLY 248 ILE 249 ILE 250 VAL 251 SER 252 ASN 253 HIS 254 GLY 255 ALA 256 ARG 257 GLN 258 LEU 259 ASP 260 TYR 261 VAL 262 PRO 263 ALA 264 THR 265 ILE 266 MET 267 ALA 268 LEU 269 GLU 270 GLU 271 VAL 272 VAL 273 LYS 274 ALA 275 ALA 276 GLN 277 GLY 278 ARG 279 ILE 280 PRO 281 VAL 282 PHE 283 LEU 284 ASP 285 GLY 286 GLY 287 VAL 288 ARG 289 ARG 290 GLY 291 THR 292 ASP 293 VAL 294 PHE 295 LYS 296 ALA 297 LEU 298 ALA 299 LEU 300 GLY 301 ALA 302 ALA 303 GLY 304 VAL 305 PHE 306 ILE 307 GLY 308 ARG 309 PRO 310 VAL 311 VAL 312 PHE 313 SER 314 LEU 315 ALA 316 ALA 317 GLU 318 GLY 319 GLU 320 ALA 321 GLY 322 VAL 323 LYS 324 LYS 325 VAL 326 LEU 327 GLN 328 MET 329 MET 330 ARG 331 ASP 332 GLU 333 PHE 334 GLU 335 LEU 336 THR 337 MET 338 ALA 339 LEU 340 SER 341 GLY 342 CYS 343 ARG 344 SER 345 LEU 346 LYS 347 GLU 348 ILE 349 SER 350 ARG 351 SER 352 HIS 353 ILE 354 ALA 355 ALA 356 ASP 357 TRP 358 ASP 359

Ligands

Unit 2

FMN 360 HST 361